Medical Marijuana Inc (MJNA)

[Spooch07]

Patent 507 is owned by the US government and the National Health
Institute gave kannalife exclusive rights to formulate a drug to treat and protect neurons from head injury and oxidative damage (which could be caused by anything under the sun--very broad. Marijuana was not rescheduled (just in my opinion) to
a class 2 to buy time with respect to patent 507. Patent 507 is also shared
With GW pharmaceuticals for a single disorder--epilepsy. It's there's until 2019, at which time it expires. Very interesting!!!